Working… Menu
Trial record 1 of 1 for:    Eicos Sciences | Phase 3
Previous Study | Return to List | Next Study

Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis (Phase 3)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04040322
Recruitment Status : Completed
First Posted : July 31, 2019
Last Update Posted : July 14, 2021
Information provided by (Responsible Party):
Eicos Sciences, Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : June 9, 2021
Actual Study Completion Date : June 9, 2021